130 related articles for article (PubMed ID: 1259932)
1. Chemotaxis for human monocytes by fibrinogen-derived peptides.
Richardson DL; Pepper DS; Kay AB
Br J Haematol; 1976 Apr; 32(4):507-13. PubMed ID: 1259932
[TBL] [Abstract][Full Text] [Related]
2. Effects of fibrinogen derivatives upon the inflammatory response. Studies with human fibrinopeptide B.
Senior RM; Skogen WF; Griffin GL; Wilner GD
J Clin Invest; 1986 Mar; 77(3):1014-9. PubMed ID: 3005361
[TBL] [Abstract][Full Text] [Related]
3. [Action of proteolytic enzymes on fibrinogen].
Jamet M; Levy G
Ann Anesthesiol Fr; 1978; 19(8):687-91. PubMed ID: 31111
[TBL] [Abstract][Full Text] [Related]
4. Sequence of fibrinogen proteolysis and platelet release after intrauterine infusion of hypertonic saline.
Nossel HL; Wasser J; Kaplan KL; LaGamma KS; Yudelman I; Canfield RE
J Clin Invest; 1979 Nov; 64(5):1371-8. PubMed ID: 500818
[TBL] [Abstract][Full Text] [Related]
5. [Thrombin-fibrinogen interaction: release of fibrinopeptides and the effects of ATP].
Gurrieri MA
Medicina (Firenze); 1990; 10(1):51-2. PubMed ID: 2381284
[TBL] [Abstract][Full Text] [Related]
6. Regulation of fibrinogen biosynthesis: effect of fibrin degradation products, low-molecular-weight peptides of fibrinogenolysis, and fibrinopeptides A and B.
Kessler CM; Bell WR
J Lab Clin Med; 1979 May; 93(5):758-67. PubMed ID: 429874
[TBL] [Abstract][Full Text] [Related]
7. Clottability and cross-linking reactivity of fibrin(ogen) following differential release of fibrinopeptides A and B.
Furlan M; Seelich T; Beck EA
Thromb Haemost; 1976 Dec; 36(3):582-92. PubMed ID: 14415
[TBL] [Abstract][Full Text] [Related]
8. [Biological properties of fibrinogen degradation products by thrombin].
Buczko W
Pol Tyg Lek; 1981 Jun; 36(23):855-6. PubMed ID: 7024948
[No Abstract] [Full Text] [Related]
9. [Endogenous peptides--physiological regulators of coagulative conversion of fibrinogen].
Byshevskiĭ ASh; Chiriat'ev EA; Leonova OP
Gematol Transfuziol; 1991 Apr; 36(4):28-31. PubMed ID: 2065963
[No Abstract] [Full Text] [Related]
10. The proteolytic action of Arvin on human fibrinogen.
Ewart MR; Hatton MW; Basford JM; Dodgson KS
Biochem J; 1970 Jul; 118(4):603-9. PubMed ID: 5529716
[TBL] [Abstract][Full Text] [Related]
11. Role of D and E domains in the migration of vascular smooth muscle cells into fibrin gels.
Kodama M; Naito M; Nomura H; Iguchi A; Thompson WD; Stirk CM; Smith EB
Life Sci; 2002 Jul; 71(10):1139-48. PubMed ID: 12095535
[TBL] [Abstract][Full Text] [Related]
12. Comparison of structures of various human fibrinogens and a derivative thereof by a study of the kinetics of release of fibrinopeptides.
Hanna LS; Scheraga HA; Francis CW; Marder VJ
Biochemistry; 1984 Sep; 23(20):4681-7. PubMed ID: 6238619
[TBL] [Abstract][Full Text] [Related]
13. Generation of forms of fragment E with differing thrombin-binding properties during digestion of fibrinogen by plasmin.
Goodwin CA; Kakkar VV; Scully MF
Biochem J; 1992 Feb; 281 ( Pt 3)(Pt 3):613-8. PubMed ID: 1531588
[TBL] [Abstract][Full Text] [Related]
14. Conversion of fibrinogen to fibrin induced by preferential release of fibrinopeptide B.
Dyr JE; Blombäck B; Hessel B; Kornalík F
Biochim Biophys Acta; 1989 Jan; 990(1):18-24. PubMed ID: 2914147
[TBL] [Abstract][Full Text] [Related]
15. Molecular basis for measurement of circulating fibrinogen derivatives.
Wilner GD
Prog Hemost Thromb; 1978; 4():211-48. PubMed ID: 152445
[TBL] [Abstract][Full Text] [Related]
16. CD11b/CD18 mediates the neutrophil chemotactic activity of fibrin degradation product D domain.
Gross TJ; Leavell KJ; Peterson MW
Thromb Haemost; 1997 May; 77(5):894-900. PubMed ID: 9184399
[TBL] [Abstract][Full Text] [Related]
17. Fibronectin and fibrinogen degradation products stimulate PMN-leukocyte and mast cell degranulation.
Wojtecka-Lukasik E; Maśliński S
J Physiol Pharmacol; 1992 Jun; 43(2):173-81. PubMed ID: 1382726
[TBL] [Abstract][Full Text] [Related]
18. The sequence of cleavage of fibrinopeptides from fibrinogen is important for protofibril formation and enhancement of lateral aggregation in fibrin clots.
Weisel JW; Veklich Y; Gorkun O
J Mol Biol; 1993 Jul; 232(1):285-97. PubMed ID: 8331664
[TBL] [Abstract][Full Text] [Related]
19. Effects of fibrinopeptide cleavage on the plasmic degradation pathways of human cross-linked fibrin.
Olexa SA; Budzynski AZ
Biochemistry; 1980 Feb; 19(4):647-51. PubMed ID: 6444516
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of fibrin polymerization by fragment d is affected by calcium, Gly-Pro-Arg and Gly-His-Arg.
Furlan M; Rupp C; Beck EA
Biochim Biophys Acta; 1983 Jan; 742(1):25-32. PubMed ID: 6824684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
